JAMP-BUPIVACAINE SOLUTION

Страна: Канада

Език: английски

Източник: Health Canada

Активна съставка:

BUPIVACAINE HYDROCHLORIDE

Предлага се от:

JAMP PHARMA CORPORATION

АТС код:

N01BB01

INN (Международно Name):

BUPIVACAINE

дозиране:

2.5MG

Лекарствена форма:

SOLUTION

Композиция:

BUPIVACAINE HYDROCHLORIDE 2.5MG

Начин на приложение:

BLOCK/INFILTRATION

Броя в опаковка:

100

Вид предписание :

Ethical

Терапевтична област:

LOCAL ANESTHETICS

Каталог на резюме:

Active ingredient group (AIG) number: 0108896001; AHFS:

Статус Оторизация:

CANCELLED PRE MARKET

Дата Оторизация:

2023-07-12

Данни за продукта

_Product Monograph – JAMP-Bupivacaine _
_Page 1 of 32 _
PRODUCT MONOGRAPH
JAMP-Bupivacaine
Bupivacaine Hydrochloride Injection USP
2.5 mg/mL and 5 mg/mL Bupivacaine Hydrochloride
(as bupivacaine hydrochloride monohydrate)
Sterile Solution
Local Anesthetic
JAMP Pharma Corporation
1380-203 newton
Boucherville, Québec
J4B 5H2
Control No. : 178342
Date of Preparation :
October 21, 2014
_Product Monograph – JAMP-Bupivacaine _
_Page 2 of 32 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT
INFORMATION........................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
3
CONTRAINDICATIONS
...................................................................................................
4
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
.................................................................................................
10
DRUG INTERACTIONS
.................................................................................................
13
DOSAGE AND ADMINISTRATION
.............................................................................
14
OVERDOSAGE
................................................................................................................
18
ACTION AND CLINICAL PHARMACOLOGY
............................................................ 21
STORAGE AND STABILITY
.........................................................................................
23
SPECIAL HANDLING INSTRUCTIONS
.......................................................................
23
DOSAGE FORMS, COMPOSITION AND PACKAGING
............................................. 23
PART II: SCIENTIFIC INFORMATION
...............................................................................
25
PHARMACEUTICAL INFORMATION
........................